|
Status |
Public on Oct 03, 2014 |
Title |
BPDCN_18 |
Sample type |
RNA |
|
|
Source name |
BPDCN Patient
|
Organism |
Homo sapiens |
Characteristics |
tumor type: BPDCN phenotype: BPDCN Patient
|
Treatment protocol |
Treatment with imatinib mesylate (0 and 1 microM) for 6 hours
|
Extracted molecule |
total RNA |
Extraction protocol |
total RNA from cryopreserved and FFPE samples was extracted using TRIzol reagent (Invitrogen) and the RecoverAll Total Nucleic Acid Isolation Kit (Ambion, Austin, TX), respectively, following the manufacturer's protocols
|
Label |
biotin
|
Label protocol |
Standard 29K Whole-Genome DASL HT Assay label protocol (WGDASL HT Assay Guide (15018210 D)
|
|
|
Hybridization protocol |
Standard 29K Whole-Genome DASL HT Assay hybridization protocol (WGDASL HT Assay Guide (15018210 D)
|
Scan protocol |
Standard 29K Whole-Genome DASL HT Assay scan protocol (WGDASL HT Assay Guide (15018210 D)
|
Data processing |
Gene expression analysis was carried according to MIAME guidelines.
|
|
|
Submission date |
Oct 02, 2014 |
Last update date |
Oct 03, 2014 |
Contact name |
Fabio Fuligni |
E-mail(s) |
fabio.fuligni2@unibo.it
|
Organization name |
University of Bologna
|
Department |
Department of Experimental, Diagnostic, and Specialty Medicine Bologna University Medical School
|
Lab |
Unit of Hematopathology
|
Street address |
Via Massarenti 9
|
City |
Bologna |
ZIP/Postal code |
40138 |
Country |
Italy |
|
|
Platform ID |
GPL18281 |
Series (1) |
GSE62014 |
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to nf-kb pathway inhibition |
|